Orthofix extends timeline for 6.5%-7.5% sales CAGR through 2028 as channel optimization matures
Source: SeekingAlpha
2026-02-24 12:08:31 ET
More on Orthofix Medical Inc.
- Orthofix Medical Inc. (OFIX) Q4 2025 Earnings Call Transcript
- Orthofix Medical Inc. 2025 Q4 - Results - Earnings Call Presentation
- Orthofix Medical beats top-line and bottom-line estimates; introduces FY26 outlook
- Seeking Alpha’s Quant Rating on Orthofix Medical Inc.
- Historical earnings data for Orthofix Medical Inc.
Read the full article on Seeking Alpha
For further details see:
Orthofix extends timeline for 6.5%-7.5% sales CAGR through 2028 as channel optimization matures
Orthofix Medical Inc.
NASDAQ: OFIX
OFIX Trading
-0.45% G/L:
$12.265 Last:
105,511 Volume:
$12.30 Open:
OFIX Latest News
February 24, 2026 07:00:00 am
Orthofix Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides 2026 Financial Guidance
OFIX Stock Data
$534,199,400
39,084,863
0.55%
48
N/A
Medical Equipment & Supplies
Healthcare
US
Lewisville
